We observed that EGR1 interacted with the promoter region of the PFKL gene, leading to the transcriptional downregulation of PFKL and the subsequent inhibition of glycolysis and proliferation in HCC cells. The gene discussed is PFKL; the disease is hepatocellular carcinoma.